Oncology Precision medicine Digital and computational pathology Omics Molecular Pathology Research and Innovations

Multiomics Improves Late-stage Melanoma Survival

How a single-cell proteomics test, run on a standard pathology slide, can reshape treatment decisions

09/09/2025 Technology 4 min read

article Full Article Summary Notecard

Share

Multiomics approach increases progression-free survival in melanoma patients.
Spatial proteomics helps tailor therapy decisions.
Study led by experts including Stéphane Chevrier.
Testing costs reduced to less than 14,000 Swiss francs.
Critical need for access to off-label drugs to improve treatment efficacy.